DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Autoimmune thyroid disease	R-HSA-1643685	map05320	levamisole	26879	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	levamisole	26879	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	levamisole	26879	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	levamisole	26879	drug-path
Asthma	R-HSA-444620	map05310	levamisole	26879	drug-path
Endometrial cancer	R-HSA-2077421	map05213	levamisole	26879	drug-path
Allograft rejection	R-HSA-9679028	map05330	levamisole	26879	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	levamisole	26879	drug-path
Complement and coagulation cascades	R-HSA-114591	map04610	levamisole	26879	drug-path
Olfactory transduction	R-HSA-9751605	map04740	levamisole	26879	drug-path
Small cell lung cancer	R-HSA-5619066	map05222	levamisole	26879	drug-path
Adherens junction	R-HSA-451386	map04520	etofylline	20299	drug-path
Olfactory transduction	R-HSA-9751605	map04740	etofylline	20299	drug-path
VEGF signaling pathway	R-HSA-194138	map04370	etofylline	20299	drug-path
Melanoma	Q9UHD0-PRO_0000015379	map05218	etofylline	20299	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	etofylline	20299	drug-path
Chronic myeloid leukemia	R-HSA-9680350	map05220	etofylline	20299	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	tranylcypromine	19493	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	tranylcypromine	19493	drug-path
Taste transduction	R-HSA-162582	map04742	tranylcypromine	19493	drug-path